Publications by authors named "Lidia Tarone"

Claim this Profile
C
Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols.
Mariateresa Camerino, Davide Giacobino, Lidia Tarone, Alfredo Dentini, Marina Martano

Vet Q· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer.
Lidia Tarone, Antonella Iacoviello, Antonino Di Lorenzo, Roberta Verta, Chiara Cossu

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the extent of cervical lymph node dissection and lymph nodes metastases on prognosis in a cohort of dogs with oral malignant melanoma treated by surgical resection and adjuvant anti-CSPG4 electrovaccination: a retrospective study on 77 cases.
Davide Giacobino, Matteo Olimpo, Erica Ilaria Ferraris, Greta Martinelli, Lorella Maniscalco, Lidia Tarone

Front Vet Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccines: Target antigens, vaccine platforms and preclinical models.
Francesca Ruzzi, Federica Riccardo, Laura Conti, Lidia Tarone, Maria Sofia Semprini

Mol Aspects Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma.
Lidia Tarone, Davide Giacobino, Mariateresa Camerino, Lorella Maniscalco, Selina Iussich

Mol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Osteosarcoma Treatment: Comparative Oncology in Action.
Lidia Tarone, Katia Mareschi, Elisa Tirtei, Davide Giacobino, Mariateresa Camerino

Life (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
Federica Riccardo, Lidia Tarone, Mariateresa Camerino, Davide Giacobino, Selina Iussich

J Immunother Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010-2020).
Mariateresa Camerino, Davide Giacobino, Luca Manassero, Selina Iussich, Federica Riccardo, Lidia Tarone

Vet Comp Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research.
Lidia Tarone, Davide Giacobino, Mariateresa Camerino, Soldano Ferrone, Paolo Buracco

Front Vet Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases.
Davide Giacobino, Mariateresa Camerino, Federica Riccardo, Federica Cavallo, Lidia Tarone

Vet Comp Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota.
Antonino Di Lorenzo, Elisabetta Bolli, Lidia Tarone, Federica Cavallo, Laura Conti

Int J Mol Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
Roberto Ruiu, Lidia Tarone, Valeria Rolih, Giuseppina Barutello, Elisabetta Bolli

Prog Mol Biol Transl Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas ​.
Federica Riccardo, Giuseppina Barutello, Angela Petito, Lidia Tarone, Laura Conti

Vaccines (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy.
Lidia Tarone, Giuseppina Barutello, Selina Iussich, Davide Giacobino, Elena Quaglino

Cancer Immunol Immunother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma.
Federica Riccardo, Lidia Tarone, Selina Iussich, Davide Giacobino, Maddalena Arigoni

Ther Adv Med Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.
Giuseppina Barutello, Valeria Rolih, Maddalena Arigoni, Lidia Tarone, Laura Conti

Int J Mol Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis